Avedro shipping Photrexa Viscous and Photrexa for cross-linking procedures

Avedro announced the launch and shipment of Photrexa Viscous and Photrexa, two FDA-approved drugs used in corneal collagen cross-linking procedures with the KXL System. In April, the FDA approved Photrexa Viscous, Photrexa and the KXL System to be used in cross-linking for the treatment of progressive keratoconus. The second indication for the products, for the treatment of corneal ectasia following refractive surgery, received FDA approval in July.